编号 |
产品名称 |
CAS号 |
规格 |
价格 |
|
A-2149 |
PKM2 activator 1020 ≥99% PKM2 activator 1020 ≥99% |
1260075-17-9 |
|
|
A-2091 |
PluriSIn #1(NSC 14613;Pluripotent cell-specific inhibitor #1) ≥99% PluriSIn #1(NSC 14613;Pluripotent cell-specific inhibitor #1) ≥99% |
91396-88-2 |
|
|
A-1624 |
威罗菲尼对照品 ≥98% PLX 4032(RG 7204;Vemurafenib;RO 5185426) ≥98% |
918504-65-1 |
|
|
A-1474 |
PLX 4720 ≥99% PLX 4720 ≥99% |
918505-84-7 |
|
|
A-1247 |
PNU 22394 HCl ≥99% PNU 22394 HCl ≥99% |
15923-42-9 |
|
|
A-1274 |
PNU 37883 HCl ≥99% PNU 37883 HCl ≥99% |
57568-80-6 |
|
|
A-1762 |
PNU 100480(PF 02341272;U 100480) ≥99% PNU 100480(PF 02341272;U 100480) ≥99% |
168828-58-8 |
|
|
A-1557 |
泊沙康唑对照品 ≥99% Posaconazole(SCH 56592;Noxafil) ≥99% |
171228-49-2 |
|
|
A-1035 |
PPHT HCl(N 0434) ≥98% PPHT HCl(N 0434) ≥98% |
71787-90-1 |
|
|
A-1036 |
(R)-PPHT HCl((R)-N 0434) ≥98% (R)-PPHT HCl((R)-N 0434) ≥98% |
161757-96-6 |
|
|
A-1037 |
(S)-PPHT HCl((S)-N 0434) ≥98% (S)-PPHT HCl((S)-N 0434) ≥98% |
159795-62-7 |
|
|
A-1595 |
PPP HCl ≥99% PPP HCl ≥99% |
21602-56-2 |
|
|
A-1231 |
PPT ≥99% PPT ≥99% |
263717-53-9 |
|
|
A-1523 |
普拉朵林对照品 ≥99% Pravadoline(WIN 48098) ≥99% |
92623-83-1 |
|
|
A-2040 |
盐酸哌唑嗪对照品 ≥99% Prazosin HCl(Furazosin HCl) ≥99% |
19237-84-4 |
|
|
A-1823 |
普瑞巴林对照品 ≥98% Pregabalin(PD 144723) ≥98% |
148553-50-8 |
|
|
A-2211 |
PRMT3 inhibitor 1(Compound 1) ≥99% PRMT3 inhibitor 1(Compound 1) ≥99% |
1340875-03-7 |
|
|
A-1284 |
2-[4-(Cyclopropylsulfonyl)phenyl]-3-(tetrahydropyran-4-yl)Propionic acid ≥98% 2-[4-(Cyclopropylsulfonyl)phenyl]-3-(tetrahydropyran-4-yl)Propionic acid ≥98% |
745052-93-1 |
|
|
A-1161 |
R(-)-N-Propylnorapomorphine HCl(NPA) ≥98% R(-)-N-Propylnorapomorphine HCl(NPA) ≥98% |
20382-71-2 |
|
|
A-1953 |
PRT 4165(NSC 600157) ≥99% PRT 4165(NSC 600157) ≥99% |
31083-55-3 |
|
|